000			01227 a2200385 4500
005			20250514045314.0
264		0	_c20021016
008			200210s 0 0 eng d
022			_a0098-7484
040			_aNLM _beng _cNLM
100	1		_aCrawford, Lester M
245	0	0	_aFrom the Food and Drug Administration. _h[electronic resource]
260			_bJAMA _cOct 2002
300			_a1579 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aBiosensing Techniques
650	0	4	_aBlood Glucose Self-Monitoring _xinstrumentation
650	0	4	_aChild
650	0	4	_aClinical Trials as Topic _xstandards
650	0	4	_aDrug Combinations
650	0	4	_aDrug Compounding _xstandards
650	0	4	_aEstrogen Replacement Therapy
650	0	4	_aEstrogens, Conjugated (USP) _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMedroxyprogesterone Acetate _xtherapeutic use
650	0	4	_aPharmacies _xlegislation & jurisprudence
650	0	4	_aPostmenopause
650	0	4	_aScientific Misconduct
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration
773	0		_tJAMA _gvol. 288 _gno. 13 _gp. 1579
999			_c12163528 _d12163528